Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients

被引：0
|
作者：
LR Coulthard
LD Church
RJ Mathews
S Churchman
L Dickie
M Buch
R Reece
A English
AW Morgan
S Gay
P Emery
MF McDermott
机构：
[1] St James's University Hospital,Leeds Institute of Molecular Medicine
[2] University Hospital,Department of Rheumatology
来源：
Arthritis Research & Therapy | / 9卷
关键词：
Rheumatoid Arthritis; Infliximab; Rheumatoid Arthritis Patient; Rheumatoid Arthritis Synovium; ACR20 Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors
    Segan, J.
    Staples, M. P.
    March, L.
    Lassere, M.
    Chakravarty, E. F.
    Buchbinder, R.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (03) : 310 - 318
  • [42] Tumour necrosis factor a-308 promoter polymorphism in patients with rheumatoid arthritis
    Rezaieyazdi, Zahra
    Afshari, Jalil Tavakol
    Sandooghi, Mahnaz
    Mohajer, Farnaz
    RHEUMATOLOGY INTERNATIONAL, 2007, 28 (02) : 189 - 191
  • [43] Effectiveness and safety of the treatment with tumour necrosis factor a antagonists in rheumatoid arthritis patients
    Mendoza, MA
    Aznárez, HN
    Hernández, MJR
    Ruiz, FJM
    MEDICINA CLINICA, 2005, 125 (01): : 35 - 36
  • [44] THE INFLUENCE OF TUMOUR NECROSIS FACTOR INHIBITORS ON DEMENTIA INCIDENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Vieira, Romana C. C.
    Watson, Kath
    Holmes, Clive
    McGuinness, Bernadette
    Hyrich, Kymme
    RHEUMATOLOGY, 2016, 55 : 73 - 74
  • [45] PREDICTING DRUG IMMUNOGENICITY TO TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Alshehri, Mohammed
    Nair, Nisha
    Yap, Chuan Fu
    Isaacs, John D.
    Hyrich, Kimme
    Morgan, Ann W.
    Wilson, Anthony G.
    Barton, Anne
    Plant, Darren
    RHEUMATOLOGY, 2022, 61 : I13 - I13
  • [46] Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland
    Aaltonen, K. J.
    Joensuu, J. T.
    Pirila, L.
    Kauppi, M.
    Uutela, T.
    Varjolahti-Lehtinen, T.
    Yli-Kerttula, T.
    Isomaki, P.
    Nordstrom, D.
    Sokka, T.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (05) : 359 - 363
  • [47] Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: An Asian perspective
    To, Kin Wang
    Gomez Reino, Juan J.
    Yoo, Dae Hyun
    Tam, Lai Shan
    RESPIROLOGY, 2013, 18 (05) : 765 - 773
  • [48] The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis
    Robak, T
    Gladalska, A
    Stepien, H
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (02) : 145 - 154
  • [49] The role of the p38 delta MAPK in the pathogenesis of rheumatoid arthritis, with a focus on IL-6 biosynthesis and responses to hypoxic stress
    Jones, D.
    Cook, G. P.
    Buch, M.
    Emery, P.
    McDermott, M. F.
    IMMUNOLOGY, 2010, 131 : 146 - 146
  • [50] p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun - The determinant role of the isoforms in the p38 MAPK signal specificity
    Pramanik, R
    Qi, XM
    Borowicz, S
    Choubey, D
    Schultz, RM
    Han, JH
    Chen, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (07) : 4831 - 4839
12345